Krebs Biochemicals & Industries (BOM:524518) LT-Debt-to-Total-Asset : 1.03 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Krebs Biochemicals & Industries's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 1.03.

Krebs Biochemicals & Industries's long-term debt to total assets ratio declined from Mar. 2023 (1.25) to Mar. 2024 (1.03). It may suggest that Krebs Biochemicals & Industries is progressively becoming less dependent on debt to grow their business.

Krebs Biochemicals & Industries LT-Debt-to-Total-Asset Historical Data

The historical data trend for Krebs Biochemicals & Industries's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries LT-Debt-to-Total-Asset Chart

Krebs Biochemicals & Industries Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.60

0.73

0.94

1.25

1.03

Krebs Biochemicals & Industries Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															1.25	-	1.00	-	1.03

Krebs Biochemicals & Industries LT-Debt-to-Total-Asset Calculation

Krebs Biochemicals & Industries's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	1835	/	1781.747
	=	1.03

Krebs Biochemicals & Industries's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	1835	/	1781.747
	=	1.03

Krebs Biochemicals & Industries (BOM:524518) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Krebs Biochemicals & Industries LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Krebs Biochemicals & Industries (BOM:524518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

KREBSBIO:India

Address

Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034

Website

http://www.krebsbiochem.com

Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines